Version 1
: Received: 24 December 2022 / Approved: 27 December 2022 / Online: 27 December 2022 (02:13:05 CET)
How to cite:
Ohe, M.; Shida, H.; Yamamoto, J.; Seki, M.; Park, Y.; Furuya, K.; Nishio, S. A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-To. Preprints2022, 2022120502. https://doi.org/10.20944/preprints202212.0502.v1
Ohe, M.; Shida, H.; Yamamoto, J.; Seki, M.; Park, Y.; Furuya, K.; Nishio, S. A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-To. Preprints 2022, 2022120502. https://doi.org/10.20944/preprints202212.0502.v1
Ohe, M.; Shida, H.; Yamamoto, J.; Seki, M.; Park, Y.; Furuya, K.; Nishio, S. A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-To. Preprints2022, 2022120502. https://doi.org/10.20944/preprints202212.0502.v1
APA Style
Ohe, M., Shida, H., Yamamoto, J., Seki, M., Park, Y., Furuya, K., & Nishio, S. (2022). A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-To. Preprints. https://doi.org/10.20944/preprints202212.0502.v1
Chicago/Turabian Style
Ohe, M., Ken Furuya and Saori Nishio. 2022 "A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-To" Preprints. https://doi.org/10.20944/preprints202212.0502.v1
Abstract
Since the beginning of 2020, tetracycline (TC), such as minocycline (MINO), has been used to inhibit coronavirus disease 2019 (COVID-19). Traditional Japanese Kampo medicine, such as Saiko-keishi-to (SKT), has recently received a lot of attention for its anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) effects. We describe a COVID-19 patient treated with MINO and SKT in anticipation of their anti-SARS-CoV-2 properties. A 90-year-old male patient with Alzheimer’s disease was referred to a medical clinic due to fever, appetite loss, and general malaise. Based on positive SARS-CoV-2 rapid antigen tests, he was diagnosed with COVID-19. He did not have COVID-19 pneumonia, but he had difficulty in eating on his own. As a result, he was referred to a hospital for admission. After admission, he was treated with molnupiravir to avoid aggravation. Seven days after his admission, he was discharged. After his discharge, he was referred to our hospital as an outpatient due to a prolonged mild fever and general malaise. As a precaution, a real-time reverse transcription-polymerase chain reaction (RT-PCR) test was performed, which yielded a positive result. Therefore, the aforementioned symptoms were thought to be caused by prolonged COVID-19. He was treated with MINO and SKT due to the anti-viral properties of these two drugs. The RT-PCR test became negative 7 days after receiving this treatment, and the fever and general malaise subsided.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
